Company / Total Assets
Twist Bioscience Corp Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$641.9M
FY2025
5-year range
$614.3M / $961.4M
FY2021-FY2025
Trend
+4.5%
vs FY2024
Sector context
#117 of 216
Health Care
What the data says
At $642M, Twist Bioscience Corp's total assets ranks #117 of 216 in the Health Care sector. Total Assets returned to growth in FY2025 after 2 years of decline, reaching $642M.
Based on SEC 10-K filings.
$642M in FY2025 with a 5-year CAGR of +10.0%.
Declined from $776M to $642M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -12.6%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
#117 of 216 in Health CareTop 54% of 216This company $641.9M Sector average $7.4B
▼
-91.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.0%, indicating consistent growth.
- In FY2025, total assets increased 4.5% year-over-year.
- Ranks #117 out of 216 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $641.9M | +4.5% |
| FY2024 | $614.3M | -20.9% |
| FY2023 | $776.4M | -19.2% |
| FY2022 | $961.4M | +36.9% |
| FY2021 | $702.1M | +76.0% |
| FY2020 | $398.9M | +113.3% |
| FY2019 | $187.0M | +61.5% |
| FY2018 | $115.8M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026